Title:
【発明の名称】シアメマジン及び非定型神経弛緩剤の組み合わせ物
Document Type and Number:
Japanese Patent JP2003516355
Kind Code:
A
Abstract:
The present invention relates to the combination of cyamemazine and an atypical neuroleptic, or a pharmaceutically acceptable salt thereof, and to the use thereof in the treatment of schizophrenia, and in particular of acute episodes of schizophrenia.
Inventors:
Dave, Michel
Leperrier, Cyril
Leperrier, Cyril
Application Number:
JP2001543114A
Publication Date:
May 13, 2003
Filing Date:
December 08, 2000
Export Citation:
Assignee:
Aventis Pharma S.A.
International Classes:
A61K45/00; A61K31/496; A61K31/519; A61K31/54; A61K31/5415; A61K31/55; A61K31/5513; A61K31/554; A61P25/18; A61P43/00; (IPC1-7): A61K31/5415; A61K31/496; A61K31/519; A61K31/5513; A61K31/554; A61K45/00; A61P25/18; A61P43/00
Foreign References:
| WO1999062522A1 | 1999-12-09 |
Other References:
JPN6011014322; Ｉｎｔ Ｊ Ｃｌｉｎ Ｐｈａｒｍａｃｏｌ Ｔｈｅｒ Ｔｏｘｉｃｏｌ． ２９（２）, 1991, ６４-６６
JPN6011014323; Ｐｈａｒｍａｃｏｌ Ｒｅｓ ３１（６）, 1995, ３４７-３５３
JPN6011014326; Ｃｌｉｎｉｃａｌ Ｎｅｕｒｏｐｈａｒｍａｃｏｌｏｇｙ １７（３）, 1994, ２３６-２４２
JPN6011014324; Ｉｎｆｏｒｍａｔｉｏｎ Ｐｓｙｃｈｉａｔｒｉｑｕｅ ５３（４）, 1977, ４９１-４９５
JPN6011014323; Ｐｈａｒｍａｃｏｌ Ｒｅｓ ３１（６）, 1995, ３４７-３５３
JPN6011014326; Ｃｌｉｎｉｃａｌ Ｎｅｕｒｏｐｈａｒｍａｃｏｌｏｇｙ １７（３）, 1994, ２３６-２４２
JPN6011014324; Ｉｎｆｏｒｍａｔｉｏｎ Ｐｓｙｃｈｉａｔｒｉｑｕｅ ５３（４）, 1977, ４９１-４９５
Attorney, Agent or Firm:
Heiyoshi Odashima